{"id":232452,"date":"2026-03-03T05:09:56","date_gmt":"2026-03-03T11:09:56","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2026\/03\/how-nanotech-made-an-old-leukemia-drug-22000x-stronger"},"modified":"2026-03-03T05:09:56","modified_gmt":"2026-03-03T11:09:56","slug":"how-nanotech-made-an-old-leukemia-drug-22000x-stronger","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2026\/03\/how-nanotech-made-an-old-leukemia-drug-22000x-stronger","title":{"rendered":"How Nanotech Made an Old Leukemia Drug 22,000x Stronger"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/how-nanotech-made-an-old-leukemia-drug-22000x-stronger.jpg\"><\/a><\/p>\n<p>Structural nanomedicine \u2014 what helped give us the COVID vaccine \u2014 may now be the key to a potent blood cancer treatment that\u2019s had remarkable early results.<\/p>\n<hr>\n<p>The findings, <a href=\"https:\/\/pubs.acs.org\/doi\/10.1021\/acsnano.5c16609\" rel=\"nofollow\" target=\"_blank\">published in <em>ACS Nano<\/em><\/a>, show that just two doses of the experimental therapy achieved 97.5% tumor growth inhibition in a human AML xenograft mouse model \u2014 59-fold more effective than standard 5-<a href=\"https:\/\/reference.medscape.com\/drug\/adrucil-fluorouracil-342092\">fluorouracil<\/a> (5-FU) treatment, with no observable side effects.<\/p>\n<p>For a disease with a grim 29% 5-year survival rate \u2014 and a cure rate of only 15% in patients older than 70 years \u2014 the findings offer a glimpse of how rethinking drug structure, not just chemistry, could advance cancer care.<\/p>\n<p>Mirkin frames the findings within what he calls \u201cthe era of structural nanomedicine,\u201d the idea that how you arrange medicinal components at the nanoscale matters as much as the molecules themselves.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Structural nanomedicine \u2014 what helped give us the COVID vaccine \u2014 may now be the key to a potent blood cancer treatment that\u2019s had remarkable early results. The findings, published in ACS Nano, show that just two doses of the experimental therapy achieved 97.5% tumor growth inhibition in a human AML xenograft mouse model \u2014 [\u2026]<\/p>\n","protected":false},"author":662,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,19,4],"tags":[],"class_list":["post-232452","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-chemistry","category-nanotechnology"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/232452","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/662"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=232452"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/232452\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=232452"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=232452"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=232452"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}